Health Organizations

Organizations around the world

World Health Organization

https://www.who.int/

WHO releases COVID-19 roadmap; funding efforts, the roadmap announced (US$42.8 million) toward the development of vaccines, therapeutics and diagnostic test. WHO has received applications for review and approval of 40 diagnostic tests, 20 vaccines and an (unspecified) number of therapeutics. There are more than 200 clinical trials targeting COVID-19 progressing in China. Those include 35 studies evaluating antivirals and other agents, including remdesivir (GS-5734), the protease inhibitor combination drug Kaletra (lopinavir +ritonavir), Truvada (tenofovir),Tamiflu (oseltamivir), Xofluza (baloxavir marboxil), Arbidol (umifenovir), interferon drugs, the antimalarial drug chloroquine, and Lianhua-Qingwen, a traditional Chinese medicine for treating flu.

who-releases-covid-19-roadmap-funding-efforts

March 11, 2020 - Declared global pandemic by the World Health Organization on March 11, 2020

NIH/NIAID

https://www.nih.gov/

National Library of Medicine

NIAID

https://www.niaid.nih.gov/diseases-conditions/coronaviruses

CDC

Recommendations for U.S. Households with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19)

https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Coronavirus

https://www.coronavirus.gov/

Coronavirus Resources

Covid 19 Alert

EPA

https://www.epa.gov/coronavirus

Products with Emerging Viral Pathogens AND Human Coronavirus claims for use against SARS-CoV-2

FDA

FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments

https://www.npr.org/sections/health-shots/2020/03/24/821035311/fda-grants-experimental-coronavirus-drug-benefits-for-rare-disease-treatments

Treatment research

Several organizations around the world are developing vaccinesor testing antiviralmedicine. Efforts include:

• US National Institutes of Health(NIH) is hoping for human trials of a vaccine by April 2020.
• The Chinese Center for Disease Control and Prevention(CCDC) has started developing vaccines against the novel coronavirus and is testing existing drug effectiveness for pneumonia.
• The Coalition for Epidemic Preparedness Innovations(CEPI) is funding three vaccine projects[269] and hopes to have a vaccine in trials by June 2020 and approved and ready in a year. The University of Queenslandin Australia has received $10.6 million in funding from CEPI to develop a "molecular clamp"[270] vaccine platform.
• Modernais developing a mRNA vaccinewith funding from CEPI. Inovio Pharmaceuticals received a grant from CEPI and designed a vaccine in two hours after receiving the gene sequence. The vaccine is being manufactured so that it can be first tested on animals.
• Hong Kongresearcher Yuen Kwok-yungand his team in the University of Hong Kongannounced that a new vaccine is developed, but needs to be tested on animals before conducting clinical tests on humans

June 25 - 254 Treatments and 172 Vaccines

Explore detailed information on each development:

Doctors Without Borders

https://www.doctorswithoutborders.org/what-we-do/news-stories

Red Cross

Redcross.org Store:first-aid-supplies

Pharmaceutical Research and Manufacturers of America

https://phrma.org/coronavirus